Mankind Pharma Ltd (MANKIND) — Cash Flow-to-Debt Ratio
Mankind Pharma Ltd (MANKIND) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2023, meaning its operating cash flow of Rs1.93 Billion could theoretically repay 0% of its total liabilities (Rs24.65 Billion) in one year. See how much free cash does Mankind Pharma Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mankind Pharma Ltd Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Mankind Pharma Ltd across 7 annual periods. Also explore Mankind Pharma Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Mankind Pharma Ltd (2019–2025)
Year-by-year debt coverage analysis for Mankind Pharma Ltd. For market capitalisation and broader financial context, see Mankind Pharma Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | Rs24.13 Billion | Rs131.91 Billion | ▼ -79.7% |
| 2024 | 0.90x | Rs21.52 Billion | Rs23.87 Billion | ▲ +2.8% |
| 2023 | 0.88x | Rs18.13 Billion | Rs20.67 Billion | ▲ +170.1% |
| 2022 | 0.32x | Rs9.20 Billion | Rs28.31 Billion | ▼ -56.9% |
| 2021 | 0.75x | Rs11.37 Billion | Rs15.10 Billion | ▼ -1.3% |
| 2020 | 0.76x | Rs10.70 Billion | Rs14.02 Billion | ▲ +43.7% |
| 2019 | 0.53x | Rs6.00 Billion | Rs11.31 Billion | — |